Global Influenza Vaccine Market 2022-2028
- SKU ID : TNV-IRTNTR20289 11413563
- |
- Publishing Date: 09-Jan-2018
- |
- Region: Global
- |
- No. of pages: 113
About Influenza Vaccine
Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.
Technavio’s analysts forecast the global influenza vaccine market to grow at a CAGR of 7.23% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• CSL
• GlaxoSmithKline
• Sanofi
Other prominent vendors
• Altimmune
• BionVax
• FluGen
• FOLIA BIOTECH
• Genentech
• Green Cross
• Medicago
• Moderna Therapeutics
• Novavax
• Shijiazhuang Yiling Pharmaceutical
• SK Chemicals
• UNM Pharma
• Vaccitech
• Vaxart
• Vaxine Pty
• Visterra.
Market driver
• Rising awareness about influenza vaccination
• For a full, detailed list, view our report
Market trend
• Development of strong pipeline
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.
Technavio’s analysts forecast the global influenza vaccine market to grow at a CAGR of 7.23% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• CSL
• GlaxoSmithKline
• Sanofi
Other prominent vendors
• Altimmune
• BionVax
• FluGen
• FOLIA BIOTECH
• Genentech
• Green Cross
• Medicago
• Moderna Therapeutics
• Novavax
• Shijiazhuang Yiling Pharmaceutical
• SK Chemicals
• UNM Pharma
• Vaccitech
• Vaxart
• Vaxine Pty
• Visterra.
Market driver
• Rising awareness about influenza vaccination
• For a full, detailed list, view our report
Market trend
• Development of strong pipeline
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
